Back to top

Buy Rating Reaffirmed for Rockwell Med amidst Strategic Growth and Operational Efficiency

Anthony Vendetti, an analyst from Maxim Group, reiterated the Buy rating on Rockwell Med (RMTI – Research Report). The associated price target is $...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Rockwell Medical, Inc. (RMTI)